KURA
Kura Oncology, Inc.$9.81-0.46 (-4.48%)Prev Close$10.26·MCap$880.7M·P/E—·Vol450.1K·Yield—
▲
Buys (12M)
2
$2.35M
▼
Sells (12M)
26
$4.11M
◆
Net Activity
Net Seller
$1.76M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Kura Oncology, Inc. (KURA) has been mixed between buying and selling, with 2 insider purchases totaling $2.35M and 26 insider sales totaling $4.11M. The most recent insider transaction was by FORD KATHLEEN (officer: Chief Operating Officer), who sold $111.9K worth of shares on Sep 29, 2026. Kura Oncology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $880.7M.
KURA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 10,574 | $10.59 | $111.9K | 146,654 |
| Sep 29, 2026 | DOYLE THOMAS JAMES | officer: SVP, Finance & Accounting | Sell | 4,607 | $10.50 | $48.4K | 142,428 |
| Sep 29, 2026 | Leoni Mollie | officer: Chief Medical Officer | Sell | 41,250 | $10.67 | $440.2K | 169,897 |
| Sep 29, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 32,450 | $10.63 | $345.0K | 160,249 |
| Sep 29, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 8,442 | $10.50 | $88.6K | 187,002 |
| Sep 25, 2026 | Burrows Francis | officer: Chief Scientific Officer | Sell | 20,726 | $10.83 | $224.5K | 42,327-33% |
| Aug 24, 2026 | WILSON TROY EDWARD | director, officer: President and CEO | Buy | 100,000 | $12.39 | $1.24M | 479,194+26% |
| Aug 24, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 4,345 | $11.89 | $51.7K | 169,269 |
| Aug 21, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 31,487 | $12.63 | $397.7K | 195,444 |
| Aug 17, 2026 | WILSON TROY EDWARD | director, officer: President and CEO | Buy | 100,000 | $11.12 | $1.11M | 379,194+36% |
| Jun 22, 2026 | Leoni Mollie | officer: Chief Medical Officer | Sell | 84,929 | $9.82 | $834.3K | 182,345-32% |
| May 22, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 10,000 | $11.00 | $110.0K | 173,614 |
| May 20, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 2,256 | $9.38 | $21.2K | 226,931 |
| May 20, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 339 | $9.21 | $3.1K | 183,614 |
| May 20, 2026 | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 2,257 | $9.08 | $20.5K | 153,560 |
| Jan 27, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 22,416 | $8.46 | $189.7K | 234,043 |
| Jan 27, 2026 | Burrows Francis | officer: Chief Scientific Officer | Sell | 2,622 | $8.46 | $22.2K | 32,424 |
| Jan 27, 2026 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 9,832 | $8.46 | $83.2K | 150,083 |
| Jan 27, 2026 | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 3,626 | $8.46 | $30.7K | 153,560 |
| Jan 27, 2026 | Leoni Mollie | officer: Chief Medical Officer | Sell | 16,360 | $8.46 | $138.4K | 271,799 |
| Jan 27, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 12,828 | $8.46 | $108.5K | 184,847 |
| Dec 18, 2025 | Burrows Francis | Chief Scientific Officer | Sell | 23,726 | $9.78 | $231.9K | 0 |
| Dec 9, 2025 | Hasnain Faheem | Director | Sell | 10,000 | $10.98 | $109.8K | 0 |
| Nov 13, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,804 | $11.18 | $98.4K | 0 |
| Nov 13, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,539 | $11.18 | $50.7K | 0 |
| Nov 13, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 6,902 | $11.18 | $77.1K | 0 |
| Nov 13, 2025 | Leoni Mollie | Chief Medical Officer | Sell | 15,485 | $11.18 | $173.1K | 0 |
| Nov 13, 2025 | Powl Brian T. | Chief Commercial Officer | Sell | 8,887 | $11.18 | $99.3K | 0 |
| Sep 27, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,805 | $8.94 | $78.7K | 0 |
| Sep 27, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,541 | $8.94 | $40.6K | 0 |
| Sep 27, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 6,892 | $8.94 | $61.6K | 0 |
| Sep 27, 2025 | Leoni Mollie | Chief Medical Officer | Sell | 12,314 | $8.94 | $110.1K | 0 |
| Sep 27, 2025 | Powl Brian T. | Chief Commercial Officer | Sell | 8,891 | $8.94 | $79.5K | 0 |
| Sep 27, 2025 | WILSON TROY EDWARD | President and CEO | Sell | 36,615 | $8.94 | $327.4K | 0 |
| Sep 8, 2025 | WILSON TROY EDWARD | President & CEO | Buy | 50,000 | $8.20 | $410.1K | 0 |
| Aug 12, 2025 | WILSON TROY EDWARD | President and CEO | Buy | 50,000 | $6.06 | $303.2K | 0 |
| May 19, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 1,559 | $5.96 | $9.3K | 0 |
| May 19, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 1,558 | $6.28 | $9.8K | 0 |
| Mar 21, 2025 | Hasnain Faheem | Director | Sell | 22,682 | $8.00 | $181.5K | 0 |
| Jan 28, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 7,281 | $7.87 | $57.3K | 112,792 |
| Jan 28, 2025 | Burrows Francis | Chief Scientific Officer | Sell | 2,166 | $7.87 | $17.1K | 22,025 |
| Jan 28, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,949 | $7.87 | $39.0K | 90,901 |
| Jan 28, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 1,817 | $7.87 | $14.3K | 21,367 |
| Jan 28, 2025 | Leoni Mollie | Chief Medical Officer | Sell | 4,963 | $7.87 | $39.1K | 90,963 |
| Jan 28, 2025 | Powl Brian T. | Chief Commercial Officer | Sell | 1,583 | $7.87 | $12.5K | 59,667 |
| Nov 19, 2024 | FORD KATHLEEN | Chief Operating Officer | Sell | 526 | $16.03 | $8.4K | 23,184 |
| May 20, 2024 | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,615 | $22.15 | $57.9K | 68,979 |
| Jan 31, 2024 | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,053 | $17.80 | $36.5K | 68,979 |
| Jan 31, 2024 | DALE STEPHEN | Chief Medical Officer | Sell | 11,983 | $19.31 | $231.4K | 46,400 |
| Jan 31, 2024 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 2,318 | $17.80 | $41.3K | 49,817 |
Showing 1–50 of 59
1 / 2
KURA Insider Buying Activity
The following table shows recent insider purchases of Kura Oncology, Inc. (KURA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | WILSON TROY EDWARD | director, officer: President and CEO | Buy | 100,000 | $12.39 | $1.24M | 479,194+26% |
| Aug 17, 2026 | WILSON TROY EDWARD | director, officer: President and CEO | Buy | 100,000 | $11.12 | $1.11M | 379,194+36% |
| Sep 8, 2025 | WILSON TROY EDWARD | President & CEO | Buy | 50,000 | $8.20 | $410.1K | 0 |
| Aug 12, 2025 | WILSON TROY EDWARD | President and CEO | Buy | 50,000 | $6.06 | $303.2K | 0 |
KURA Insider Selling Activity
The following table shows recent insider sales of Kura Oncology, Inc. (KURA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 10,574 | $10.59 | $111.9K | 146,654 |
| Sep 29, 2026 | DOYLE THOMAS JAMES | officer: SVP, Finance & Accounting | Sell | 4,607 | $10.50 | $48.4K | 142,428 |
| Sep 29, 2026 | Leoni Mollie | officer: Chief Medical Officer | Sell | 41,250 | $10.67 | $440.2K | 169,897 |
| Sep 29, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 32,450 | $10.63 | $345.0K | 160,249 |
| Sep 29, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 8,442 | $10.50 | $88.6K | 187,002 |
| Sep 25, 2026 | Burrows Francis | officer: Chief Scientific Officer | Sell | 20,726 | $10.83 | $224.5K | 42,327-33% |
| Aug 24, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 4,345 | $11.89 | $51.7K | 169,269 |
| Aug 21, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 31,487 | $12.63 | $397.7K | 195,444 |
| Jun 22, 2026 | Leoni Mollie | officer: Chief Medical Officer | Sell | 84,929 | $9.82 | $834.3K | 182,345-32% |
| May 22, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 10,000 | $11.00 | $110.0K | 173,614 |
| May 20, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 2,256 | $9.38 | $21.2K | 226,931 |
| May 20, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 339 | $9.21 | $3.1K | 183,614 |
| May 20, 2026 | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 2,257 | $9.08 | $20.5K | 153,560 |
| Jan 27, 2026 | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 22,416 | $8.46 | $189.7K | 234,043 |
| Jan 27, 2026 | Burrows Francis | officer: Chief Scientific Officer | Sell | 2,622 | $8.46 | $22.2K | 32,424 |
| Jan 27, 2026 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 9,832 | $8.46 | $83.2K | 150,083 |
| Jan 27, 2026 | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 3,626 | $8.46 | $30.7K | 153,560 |
| Jan 27, 2026 | Leoni Mollie | officer: Chief Medical Officer | Sell | 16,360 | $8.46 | $138.4K | 271,799 |
| Jan 27, 2026 | Powl Brian T. | officer: Chief Commercial Officer | Sell | 12,828 | $8.46 | $108.5K | 184,847 |
| Dec 18, 2025 | Burrows Francis | Chief Scientific Officer | Sell | 23,726 | $9.78 | $231.9K | 0 |
| Dec 9, 2025 | Hasnain Faheem | Director | Sell | 10,000 | $10.98 | $109.8K | 0 |
| Nov 13, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,804 | $11.18 | $98.4K | 0 |
| Nov 13, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,539 | $11.18 | $50.7K | 0 |
| Nov 13, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 6,902 | $11.18 | $77.1K | 0 |
| Nov 13, 2025 | Leoni Mollie | Chief Medical Officer | Sell | 15,485 | $11.18 | $173.1K | 0 |
| Nov 13, 2025 | Powl Brian T. | Chief Commercial Officer | Sell | 8,887 | $11.18 | $99.3K | 0 |
| Sep 27, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,805 | $8.94 | $78.7K | 0 |
| Sep 27, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,541 | $8.94 | $40.6K | 0 |
| Sep 27, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 6,892 | $8.94 | $61.6K | 0 |
| Sep 27, 2025 | Leoni Mollie | Chief Medical Officer | Sell | 12,314 | $8.94 | $110.1K | 0 |
| Sep 27, 2025 | Powl Brian T. | Chief Commercial Officer | Sell | 8,891 | $8.94 | $79.5K | 0 |
| Sep 27, 2025 | WILSON TROY EDWARD | President and CEO | Sell | 36,615 | $8.94 | $327.4K | 0 |
| May 19, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 1,559 | $5.96 | $9.3K | 0 |
| May 19, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 1,558 | $6.28 | $9.8K | 0 |
| Mar 21, 2025 | Hasnain Faheem | Director | Sell | 22,682 | $8.00 | $181.5K | 0 |
| Jan 28, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | 7,281 | $7.87 | $57.3K | 112,792 |
| Jan 28, 2025 | Burrows Francis | Chief Scientific Officer | Sell | 2,166 | $7.87 | $17.1K | 22,025 |
| Jan 28, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,949 | $7.87 | $39.0K | 90,901 |
| Jan 28, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | 1,817 | $7.87 | $14.3K | 21,367 |
| Jan 28, 2025 | Leoni Mollie | Chief Medical Officer | Sell | 4,963 | $7.87 | $39.1K | 90,963 |
| Jan 28, 2025 | Powl Brian T. | Chief Commercial Officer | Sell | 1,583 | $7.87 | $12.5K | 59,667 |
| Nov 19, 2024 | FORD KATHLEEN | Chief Operating Officer | Sell | 526 | $16.03 | $8.4K | 23,184 |
| May 20, 2024 | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,615 | $22.15 | $57.9K | 68,979 |
| Jan 31, 2024 | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,053 | $17.80 | $36.5K | 68,979 |
| Jan 31, 2024 | DALE STEPHEN | Chief Medical Officer | Sell | 11,983 | $19.31 | $231.4K | 46,400 |
| Jan 31, 2024 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 2,318 | $17.80 | $41.3K | 49,817 |
KURA Insiders
Similar Stocks to KURA
MRNA
Moderna, Inc.
$226.04+1.59%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$961.54+3.63%
$83.15B
RVMD
Revolution Medicines, Inc.
$189.30-1.11%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$161.07-2.41%
$30.46B
UTHR
United Therapeutics Corporation
$596.10-0.44%
$25.15B
INCY
Incyte Corporation
$119.46-0.77%
$23.69B
INSM
Insmed Incorporated
$110.72-1.71%
$21.18B
EXEL
Exelixis, Inc.
$70.77+1.97%
$16.64B